99% Savings - Buy Just @1 Rs X
Benelix BR 50/1.25/4 Syrup is a prescription medicine that is available as a Syrup. Benelix BR 50/1.25/4 Syrup also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Benelix BR 50/1.25/4 Syrup. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Benelix BR 50/1.25/4 Syrup are Skin Rash, Epigastric Pain, Bronchospasm. Some other side effects of Benelix BR 50/1.25/4 Syrup have been listed ahead. Normally, these side effects of Benelix BR 50/1.25/4 Syrup are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Benelix BR 50/1.25/4 Syrup's effect is Severe during pregnancy and Severe for lactating mothers. Warnings related to Benelix BR 50/1.25/4 Syrup's effects on the liver, heart and kidney, if any, have been listed below.
Benelix BR 50/1.25/4 Syrup is not recommended if you suffer from certain medical conditions as it can have adverse effects. Asthma, Smoking Addiction are examples of such conditions. Other contraindications of Benelix BR 50/1.25/4 Syrup have been discussed in the sections ahead.
Additionally, Benelix BR 50/1.25/4 Syrup may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Benelix BR 50/1.25/4 Syrup is considered not safe while driving, and is not addictive.
Benelix BR 50/1.25/4 Syrup is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Benelix BR 50/1.25/4 Syrup safe for pregnant women?
Benelix BR should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Benelix BR 50/1.25/4 Syrup safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Benelix BR. It should only be taken after medical advice.
What is the effect of Benelix BR 50/1.25/4 Syrup on the Kidneys?
There can be some harmful effects on your kidneys after taking Benelix BR. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Benelix BR 50/1.25/4 Syrup on the Liver?
Benelix BR may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Benelix BR 50/1.25/4 Syrup on the Heart?
Benelix BR has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Benelix BR 50/1.25/4 Syrup unless your doctor advises you to do so -
Is this Benelix BR 50/1.25/4 Syrup habit forming or addictive?
No, you will not get addicted to Benelix BR 50/1.25/4 Syrup.
Interaction between Food and Benelix BR 50/1.25/4 Syrup
Information is not available on the interaction of any foods with Benelix BR 50/1.25/4 Syrup, due to a lack of research on this.
Interaction between Alcohol and Benelix BR 50/1.25/4 Syrup
No research has been done on this till date. Therefore, it is not known what the effect of taking Benelix BR 50/1.25/4 Syrup with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Guaifenesin
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 629-631
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1182-1183
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219